[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100410281":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":29,"centralContacts":34,"locations":44,"responsibleParty":83,"collaborators":10,"id":85,"slug":10,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":10,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":10,"studyType":97,"phases":10,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"Proteocyte Diagnostics Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Oral Mucosal Biopsies With or Without Evidence of Epithelial Dysplasia",null,"No evidence of dysplasia\n\nMild dysplasia\n\nModerate dysplasia\n\nSevere dysplasia",[13,14],"Procedure: Standard of Care Histopathology","Procedure: STRATICYTE Assessment",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"PROCEDURE","Standard of Care Histopathology","Assessment for mild, moderate, or severe dysplasia, and risk of progression to oral cancer",[9],[22],"H&E assessment for dysplasia grade",{"type":17,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"STRATICYTE Assessment","Assessment for risk of progression to oral cancer",[9],[28],"S100A7 Immunohistochemistry Signature-based Assessment",[30],{"name":31,"affiliation":32,"role":33},"Mark Darling, MSc, MChD","Western University","PRINCIPAL_INVESTIGATOR",[35,40],{"name":36,"role":37,"phone":38,"phoneExt":10,"email":39},"Jason Hwang, PhD","CONTACT","(647) 255-1370","jhwang@proteocyte.com",{"name":31,"role":37,"phone":41,"phoneExt":42,"email":43},"(519) 661-2111","86399","mark.darling@schulich.uwo.ca",[45,62,71],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Kingsway Oral & Maxillofacial Surgery","RECRUITING","Edmonton","Alberta","T5M 3Z7","Canada",{"type":53,"coordinates":54},"Point",[55,56],-113.46871,53.55014,{"lat":56,"lon":55},[59,61],{"name":60,"role":37,"phone":10,"phoneExt":10,"email":10},"Tim McGaw, DDS, MSc, MD",{"name":60,"role":33,"phone":10,"phoneExt":10,"email":10},{"facility":63,"status":47,"city":48,"state":49,"zip":64,"country":51,"cosmosGeoPoint":65,"geoPoint":67,"contacts":68},"University of Alberta","T6G 1C9",{"type":53,"coordinates":66},[55,56],{"lat":56,"lon":55},[69,70],{"name":60,"role":37,"phone":10,"phoneExt":10,"email":10},{"name":60,"role":33,"phone":10,"phoneExt":10,"email":10},{"facility":32,"status":47,"city":72,"state":73,"zip":74,"country":51,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"London","Ontario","N6A 5C1",{"type":53,"coordinates":76},[77,78],-81.23304,42.98339,{"lat":78,"lon":77},[81,82],{"name":31,"role":37,"phone":10,"phoneExt":10,"email":10},{"name":31,"role":33,"phone":10,"phoneExt":10,"email":10},{"type":84,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100410281",false,"NCT04622462","Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment","A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE","Inclusion Criteria:\n\n* Any clinically suspicious lesion biopsied to rule-out oral epithelial dysplasia\u002Foral squamous cell carcinoma\n\nExclusion Criteria:\n\n* Biopsied lesion with or without dysplasia concomitant with oral squamous cell carcinoma at initial biopsy","ALL","15 Years","90 Years",{"count":95,"type":96},500,"ESTIMATED","OBSERVATIONAL","The purpose of this observational study is to evaluate the utility of the S100A7 immunohistochemistry signature-based assessment - STRATICYTE - in determining the risk of progression to cancer of clinically suspicious oral lesions.",[100],"Oral Neoplasm",[102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133],"Leukoplakia","Erythroplakia","Erythroleukoplakia","Lesion","Oral Epithelial Dysplasia","S100A7 Biomarker","S100A7 Immunohistochemistry Signature-based","Early Diagnosis","STRATICYTE","Oral Neoplasia","Oral Epithelial Atypia","Hyperplasia","Hyperkeratosis","Oral Squamous Cell Carcinoma","Oral Cancer","Potentially Premalignant Oral Epithelial Lesion","OPMD","Mild Dysplasia","Moderate Dysplasia","Severe Dysplasia","Low-grade Dysplasia","High-grade Dysplasia","Personalized Medicine","Predictive Assay","Whole Slide Imaging","Computational Pathology","Digital Pathology","Artificial Intelligence","Machine Learning","OPML","Oral Potentially Malignant Disorder","Oral Potentially Malignant Lesion","2024-11-05",{"date":136,"type":137},"2024-11-07","ACTUAL",{"date":139,"type":137},"2015-03-12",{"date":141,"type":96},"2026-12-31",{"name":5,"class":6},3]